SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-214382
Filing Date
2019-08-07
Accepted
2019-08-07 06:03:10
Documents
50
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d779433d10q.htm   iXBRL 10-Q 1204225
2 EX-31.1 d779433dex311.htm EX-31.1 10723
3 EX-31.2 d779433dex312.htm EX-31.2 10722
4 EX-32.1 d779433dex321.htm EX-32.1 4992
  Complete submission text file 0001193125-19-214382.txt   4115927

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20190630.xsd EX-101.SCH 25090
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20190630_cal.xml EX-101.CAL 27358
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20190630_def.xml EX-101.DEF 87348
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20190630_lab.xml EX-101.LAB 236880
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20190630_pre.xml EX-101.PRE 184118
10 EXTRACTED XBRL INSTANCE DOCUMENT d779433d10q_htm.xml XML 693301
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 191003718
SIC: 2834 Pharmaceutical Preparations